APA-referens (7:e uppl.)

Akimoto, M., Miyazaki, T., Takahashi, H., Saigusa, Y., Takeda, T., Hibino, Y., . . . Nakajima, H. (2024). Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse. International Journal of Hematology, 119(2), 164-172. https://doi.org/10.1007/s12185-023-03700-0

Chicago-referens (17:e uppl.)

Akimoto, Masahiro, et al. "Comparison of Standardized Prophylactic High-dose and Intrathecal Methotrexate for DLBCL with a High Risk of CNS Relapse." International Journal of Hematology 119, no. 2 (2024): 164-172. https://doi.org/10.1007/s12185-023-03700-0.

MLA-referens (9:e uppl.)

Akimoto, Masahiro, et al. "Comparison of Standardized Prophylactic High-dose and Intrathecal Methotrexate for DLBCL with a High Risk of CNS Relapse." International Journal of Hematology, vol. 119, no. 2, 2024, pp. 164-172, https://doi.org/10.1007/s12185-023-03700-0.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.